These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2941304)

  • 1. Recognition of exon-shuffled class II molecules by T helper cells.
    Wegmann DR; Roeder WD; Shutter JR; Kop J; Chiller JM; Maki RA
    Eur J Immunol; 1986 Jun; 16(6):671-8. PubMed ID: 2941304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
    Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
    Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.
    Janeway CA; Haque S; Smith LA; Saizawa K
    J Mol Cell Immunol; 1987; 3(2):121-31. PubMed ID: 2978238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
    Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
    J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D.
    Fairchild RL; Kubo RT; Moorhead JW
    J Immunol; 1990 Oct; 145(7):2001-9. PubMed ID: 1697873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.
    Ronchese F; Brown MA; Germain RN
    J Immunol; 1987 Jul; 139(2):629-38. PubMed ID: 3110276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor gene segment usage in a panel of hen-egg white lysozyme specific, I-Ak-restricted T helper hybridomas.
    Johnson NA; Carland F; Allen PM; Glimcher LH
    J Immunol; 1989 May; 142(9):3298-304. PubMed ID: 2468715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c.
    Winoto A; Urban JL; Lan NC; Goverman J; Hood L; Hansburg D
    Nature; 1986 Dec 18-31; 324(6098):679-82. PubMed ID: 3025740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.
    Wilde DB; Marrack P; Kappler J; Dialynas DP; Fitch FW
    J Immunol; 1983 Nov; 131(5):2178-83. PubMed ID: 6195255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocyte activation upon exclusive recognition of major histocompatibility antigens by T helper cells.
    Pobor G; Pettersson S; Bandeira A; Martinez-A C; Coutinho A
    Eur J Immunol; 1984 Mar; 14(3):222-7. PubMed ID: 6200332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of B cells by autoreactive T cells: cloned autoreactive T cells activate B cells by two distinct pathways.
    Finnegan A; Needleman B; Hodes RJ
    J Immunol; 1984 Jul; 133(1):78-85. PubMed ID: 6202794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.